The work is happening at a nuclear power plant in Cernavodă. Construction workers break ground on first-of-its-kind nuclear ...

Each month, we highlight a child in need of a forever family in Region 8. This month, we reintroduce you to 16-year-old Lily.

CDSCO allows Lilly to launch weight-loss drug Mounjaro in pen format The KwikPen is a multi-dose, single-patient-use prefilled pen designed for once-in-a week administration ...

Pharma Battle: Lilly gains CDSCO approval to launch Mounjaro KwikPen in India, challenging Novo Nordisk’s Wegovy in obesity drug market.

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro pen, its widely used diabetes and weight-loss drug. Available in six dosages, Mounjaro helps manage type 2 ...

Eli Lilly's Mounjaro diabetes and weight-loss drug approved in India in KwikPen device, offering personalized treatment options.

Lilly's new plant in North Carolina, which is the company's second in the state, uses a mix of automation and robotics to crank out injectable drugs.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving it more options to compete with ...

The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use intravenously.

Jefferies analysts called the proxy filing, which is a standard disclosure after a merger agreement, “much more intriguing than normal” given the regulatory turmoil it revealed.

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a fast-growing market.